14 categories and 72 products and companies, charted by an ai agent.
AI antigen design uses machine learning to computationally identify and optimize antigenic sequences for vaccine development. Biotech firms, vaccine manufacturers, and research institutions use these platforms to accelerate candidate selection before synthesis and testing.
moderna · biontech · vaccitech · evaxion biotech · cradle bio · nec oncommunity · gritstone bio · generative protein design · vaxine · evaxion
modernatx mrna-4157 · biontech bnt111 · nec bio necvax-neo1 · ineo-tec · genocea biosciences · elicio therapeutics
Platforms that use machine learning to predict which protein sequences are likely to trigger immune responses (epitopes) in vaccines. Vaccine developers, immunologists, and biotech companies use these to identify candidate antigens before clinical testing.
evaxion ai-immune · deepmind alphafold · iedb tools (lji) · netmhcpan · pepfun / pepatch ai
mRNA vaccine design AI uses machine learning to optimize mRNA sequences, codon usage, and secondary structures for therapeutic vaccines. Pharmaceutical companies, biotech firms, and vaccine manufacturers use these tools to accelerate candidate selection and manufacturing feasibility.
moderna ai platform · curevac · arctus biotherapeutics · translate bio (sanofi) · openai x moderna
Clinical trial optimization AI applies machine learning to design, recruit for, and monitor vaccine trials, reducing timelines and improving statistical power. Pharmaceutical companies, CROs, and biotech firms use these platforms to streamline Phase I-III protocols.
medidata (dassault) · veeva vault · unlearn.ai · science 37 · inato
oracle health sciences · veeva vault safety · aris global argus · saama technologies
bluedot · metabiota · healthmap (boston children's) · ginkgo bioworks pathogen surveillance · who eios · airfinity · healthmap
controlant · sensitech (carrier) · zest labs · parsyl
Protein structure-based vaccine design uses computational models of protein structures to identify and design immunogenic antigens for vaccine development. Pharmaceutical companies, biotech firms, and academic research groups use these platforms to accelerate vaccine candidate discovery.
pfizer paxlovid structure ai · insilico medicine · schrodinger · absci
pfizer ai labs · merck (msd) ai · sanofi ai center · gsk ai hub · johnson & johnson innovative medicine ai · serum institute ai · astrazeneca ai center
Protein structure models predict 3D shapes of proteins from amino acid sequences to guide vaccine design. Vaccine developers, immunologists, and biotech researchers use these models to identify epitopes and design immunogenic antigens.
alphafold · evolutionaryscale · isomorphic labs · chai discovery · profluent
Cancer neoantigen vaccines are personalized immunotherapies that train a patient's immune system to recognize mutations specific to their tumor. Oncologists and patients with solid tumors use these vaccines, typically combined with checkpoint inhibitors, to target cancer cells carrying those mutations.
nec oncoimmunity · nouscom · immunai
Vaccine manufacturing and cold chain encompasses the physical production facilities, storage systems, and logistics networks that maintain temperature-controlled environments for vaccine handling from manufacturing through distribution to clinical sites. Pharmaceutical manufacturers, logistics providers, and healthcare systems use these systems to preserve vaccine viability.
zipline · emerson · tive · sensitech
Vaccine safety surveillance monitors adverse events and safety signals in vaccinated populations through automated data collection, analysis and reporting systems. Public health agencies, regulatory bodies, and vaccine manufacturers use these platforms to detect safety issues post-deployment.
iqvia · linguamatics · aetion